Select Page
Follow-up cholesterol testing reduces risk of reocurrence for heart attack, stroke patients

Follow-up cholesterol testing reduces risk of reocurrence for heart attack, stroke patients

If you have a heart attack or stroke, it’s important to get your “bad” cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering another serious cardiovascular episode.

The new research, conducted by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City, found that patients who don’t follow up with their doctor by getting a low-density lipoprotein (LDL) cholesterol test following a heart attack or stroke are significantly more likely to have a reccurrence. (more…)

Follow-up cholesterol testing reduces risk of reocurrence for heart attack, stroke patients

Heart attack and stroke patients prescribed statin medication upon discharge have better outcomes

Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they’re discharged from the hospital, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City.

Prior surveys in hospitals found that statins, a common medication prescribed to lower cholesterol, aren’t being used as consistently in patients who’ve been admitted to the hospital following a heart attack or stroke. Researchers also found that when the medication is prescribed, dosing is likely not as high as it should be to provide optimal benefits. (more…)

Follow-up cholesterol testing reduces risk of reocurrence for heart attack, stroke patients

Landmark study may impact standard stroke treatment guidelines

Standard guidelines for stroke treatment currently recommend clot removal only within six hours of stroke onset. But a milestone study with results published in the New England Journal of Medicine shows that clot removal up to 24 hours after stroke led to significantly reduced disability for properly selected patients.

The international multi-center clinical study, known as the DAWN trial, randomly assigned 206 stroke victims who arrived at the hospital within six to 24 hours to either endovascular clot removal therapy, known as thrombectomy, or to standard medical therapy. (more…)

Follow-up cholesterol testing reduces risk of reocurrence for heart attack, stroke patients

Blood-clotting protein prevents repair in the brain

Picture a bare wire, without its regular plastic coating. It’s exposed to the elements and risks being degraded. And, without insulation, it may not conduct electricity as well as a coated wire. Now, imagine this wire is inside your brain.

That’s what happens in many diseases of the nervous system, such as multiple sclerosis (MS), spinal cord injuries, stroke, neonatal brain injuries, and even Alzheimer’s disease.

Much like that bare wire, the nerve fibers in the brain lose their protective coating, called myelin, and become extremely vulnerable. This leaves the nerve cells exposed to their environment and reduces their ability to transmit signals quickly, resulting in impaired cognition, sensation, and movement. (more…)

Patients and carers expertise important for the credibility of the European Stroke Action Plan

Patients and carers expertise important for the credibility of the European Stroke Action Plan

Bo Norrving is a professor in neurology at Lund University, Sweden. He has authored more than 400 publications on clinical stroke research, including several seminal papers e.g. the Swedish Aspirin Low Dose Study, and the world’s largest study of stroke in the young. He is a founder of the Swedish Stroke Register (Riksstroke), the world’s 1st national stroke registry. He is a member of the advisory group for ICD 11 at WHO. He was the President of the World Stroke Organization (WSO) 2008-2012, and chairs the WSO Global Policy Committee. He is the editor-in-chief of the European Stroke Journal.

Having in mind that he was one of the editors of the important 2006 Helsingborg Declaration on European stroke strategies, the European Stroke Organisation and SAFE are proud and honored to have Prof. Norrving now coordinating a joint ESO and SAFE project called “Stroke Action Plan for Europe 2018-2030”.

Prof. Bo Norrving; Photo: Henrik Rosenqvist

SAFE: Stroke Support Organisations are only just beginning to be formed and to grow in quite a lot of countries; do you think that medics are fully aware of how important they are in influencing decision makers on allocations of funding and resources to things like stroke care, stroke research and public awareness? If not as aware what is ESO doing to encourage medics to aid the growth of SSO?

BN: I think the full importance is still not well recognized. There are many examples where the initiatives of SSOs have been critically important. It’s an important task for ESO to support formation of new SSOs and to support and collaborate with existing ones. ESO and SAFE have recently joined forces in several actions and projects (e.g. at the EU, the European Stroke Action Plan), and I am sure there will be many more in the future. (more…)

Empowering stroke advocates through an e-learning tool

Empowering stroke advocates through an e-learning tool

A new and exciting e-learning tool is being developed by SAFE to support Stroke Support Organisations around positive and effective stroke advocacy

The Stroke Alliance For Europe (SAFE) in partnership with the European Stroke Organisation (ESO) has begun to develop a new online e-learning tool for empowering stroke advocates from across Europe. The Stroke Support Organisation Faculty Tool (SSOFT) will help to build the capacity and capabilities of Stroke Support Organisations (SSOs) by developing their knowledge and understanding around how to build positive and effective advoacy campaigns for stroke prevention, diagnosis and treatment. (more…)